Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03153371 · ClinicalTrials.gov registry record
Early-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural Networks
A clinical trial, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 180
- Enrollment target
NCT03153371: Completed study, sponsored by University of California, Los Angeles.
NCT03153371 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 180 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03153371 has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 180 participants
- Enrollment target
Study Summary
This study attempts to identify two types of AD by using clinical and cognitive tasks and brain imaging. The subtypes of AD are separated into a "typical" group (memory loss) and a "variant" group (language, visuospatial, and other cognitive difficulties). Performance on the clinical tasks and brain imaging will be compared among the young-onset Alzheimer's disease group, a late-onset Alzheimer's disease group, and a control group.
Primary Outcome
Neuropsychological testing results for use in a two-stage multivariate diagnostic method that combines the (weighted) test results in order to best discriminate Type 2 AD and typical AD.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2016-04-04 |
| Est. Completion | 2021-08-31 |
What the finished NCT03153371 record still lists
NCT03153371 is an observational study that tracks outcomes without assigning an intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03153371 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03153371 about?
NCT03153371 is a clinical study titled "Early-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural Networks". This study attempts to identify two types of AD by using clinical and cognitive tasks and brain imaging. The subtypes of AD are separated into a "typical" group (memory loss) and a "variant" group (language, visuospatial, and other cognitive difficulties). Performance on the clinical tasks and brain...
What is the current status of trial NCT03153371?
This trial is currently completed. The enrollment target is 180 participants. The study started on 2016-04-04. Estimated completion is 2021-08-31.
Who is sponsoring clinical trial NCT03153371?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI